Replimune Group (REPL) Institutional Ownership

92.53% of Replimune Group's stock is owned by institutional investors. Learn more on REPL's institutional investor holdings.

Of the 153 institutional investors that purchased Replimune Group's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Braidwell LP ($4.38M), Millennium Management LLC ($2.72M), Readystate Asset Management LP ($2.57M), Balyasny Asset Management L.P. ($2.29M), Erste Asset Management GmbH ($2.12M), State Street Corp ($1.95M), and Adage Capital Partners GP L.L.C. ($1.81M).

Institutional investors have bought a total of 25,357,217 shares in the last 24 months. This purchase volume represents approximately $180.00M in transactions.

Of the 56 institutional investors that sold Replimune Group's stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Balyasny Asset Management L.P. ($2.60M), Fcpm Iii Services B.V. ($1.35M), Boxer Capital Management LLC ($1.16M), Braidwell LP ($1.04M), Marshall Wace LLP ($621.16K), Deutsche Bank AG ($485.62K), and Goldman Sachs Group Inc. ($476.66K).

Institutional investors have sold a total of 11,792,862 shares in the last 24 months. This volume of shares sold represents approximately $101.37M in transactions.